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Abstract
Background: Different methods of evaluating diagnostic performance when comparing diagnostic tests may lead to
different results. We compared two such approaches, sensitivity and specificity with area under the Receiver Operating
Characteristic Curve (ROC AUC) for the evaluation of CT colonography for the detection of polyps, either with or without
computer assisted detection.
Methods: In a multireader multicase study of 10 readers and 107 cases we compared sensitivity and specificity, using
radiological reporting of the presence or absence of polyps, to ROC AUC calculated from confidence scores concerning the
presence of polyps. Both methods were assessed against a reference standard. Here we focus on five readers, selected to
illustrate issues in design and analysis. We compared diagnostic measures within readers, showing that differences in results
are due to statistical methods.
Results: Reader performance varied widely depending on whether sensitivity and specificity or ROC AUC was used. There
were problems using confidence scores; in assigning scores to all cases; in use of zero scores when no polyps were
identified; the bimodal non-normal distribution of scores; fitting ROC curves due to extrapolation beyond the study data;
and the undue influence of a few false positive results. Variation due to use of different ROC methods exceeded differences
between test results for ROC AUC.
Conclusions: The confidence scores recorded in our study violated many assumptions of ROC AUC methods, rendering
these methods inappropriate. The problems we identified will apply to other detection studies using confidence scores. We
found sensitivity and specificity were a more reliable and clinically appropriate method to compare diagnostic tests.
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Introduction
Comparisons of diagnostic tests aim to inform healthcare
providers and patients which tests are most accurate. The ideal test
would give all patients a correct diagnosis, in a short time and with
minimal inconvenience to the patient. Unfortunately no test is
perfect, and in practice some patients with the target disease will
be missed (false negative result), and some patients without disease
will be diagnosed incorrectly with disease (false positive result).
Measuring diagnostic performance
There are three main approaches for comparing diagnostic test
accuracy that use different statistical measures. In a previous paper
we have discussed these approaches with illustrative examples [1].
The first approach is to use paired measures at specific test
thresholds, using either sensitivity and specificity, positive predic-
tive value and negative predictive value (PPV and NPV), or
positive likelihood ratio and negative likelihood ratio (LR+ and
LR2). A second approach is to examine test performance across
all diagnostic test thresholds, using summary measures such as
ROC AUC or diagnostic odds ratio (DOR). A third approach
gives an overall measure at a specific threshold (or series of
thresholds), reported alongside the paired measures for example
using a weighted comparison measure [2,3] or net benefit [4,5];
using a single measure can be to simplify comparisons of overall
results compared to using paired measures that are likely to change
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in different directions, of which sensitivity and specificity are the
best known examples.
Multi-Reader Multi-Case designs
In radiology, multi-reader multi-case (MRMC) studies are often
used to compare the diagnostic accuracy of alternative imaging
approaches and this design is currently required by the United
States Food and Drug Administration (FDA) for pre-market
evaluation [6]. Key attributes of good study design are uncontro-
versial and include interpretation of medical images from the
clinical population of interest by radiologists typical of those who
would read the test in clinical practice, and unaware of the patient
disease status or prevalence of abnormality. Studies often compare
test interpretation by the same radiologists in the same patients,
with the only difference being the diagnostic test. Multi-reader
multi-case studies can either use a fully crossed design, where all
readers interpret all patient images or split-plot designs [7].
Learning and order bias are reduced by presenting images and
tests to each reader in random order. Interpretation of the same
case is often separated by at least one month to reduce potential
for recall bias.
Clinical utility of CT colonography
Computed tomography (CT) colonography is a CT scanning
technique used to identify colon polyps, the precursor of colon
cancer. Diagnostic improvement occurs when correct detection of
patients with polyps increases (false negative results are reduced),
corresponding to an increase in sensitivity, without an unaccept-
able increase in false positive diagnoses, corresponding to a
decrease in specificity. It is important to take disease prevalence
into account when balancing changes in sensitivity and specificity.
We have recently measured the relative value that patients and
clinicians place on false positive results compared to false negative
results using discrete choice experiments [8]. Both patients and
medical professionals valued reducing false negative (increasing
sensitivity) more desirable than reducing false positive results
(reduction in specificity) for both colon polyps and colon cancer
[8]. Similarly when in mammography screening women will
exchange 500 false-positives for one additional cancer [9]. This is
pertinent to ROC AUC, where the analysis automatically sets a
weighting of the relative importance of diagnoses [1].
Sensitivity and specificity are usually direct measures calculated
from diagnostic data reported by radiologists in normal clinical
practice, namely the presence or absence of polyps. By contrast
ROC AUC is a summary measure of performance across all
potential diagnostic thresholds for positivity, rather than perfor-
mance at any specific threshold. As such ROC AUC is classified as
a surrogate endpoint [10].
ROC AUC requires confidence scores
ROC AUC is derived from confidence scores which are scores
usually assigned by radiologists to indicate their confidence in their
diagnosis. Confidence scores may or may not form part of the
normal clinical report. Confidence scores can be assigned either to
individual lesions within a patient, or to an overall patient
diagnosis.
In imaging studies there are two broad types of clinical scenario
in which confidence scores can be assigned to enable calculation of
ROC AUC. In ‘‘classification’’ studies, visualised lesions are
classified according to morphological characteristics perceived by
the radiologist; for example in mammography studies lesions are
either benign or malignant and the strength of the radiologist’s
belief is captured using a confidence scale such as ‘benign’,
‘probably benign’, ‘equivocal’, ‘probably malignant’, or ‘definitely
malignant’. If there is a lesion on every image presented, then the
task is purely classification. In some studies the confidence score is
adapted from a clinical measure used in clinical practice, such as
the BI-RAD scale [11].
In ‘‘detection’’ or ‘‘presence versus absence’’ studies, readers are
asked to record their confidence regarding the presence or absence
of a lesion rather than its nature; often a scale such as 0 to 100 is
used. These confidence scores are often recorded in clinical trials
solely to calculate ROC AUC. It has been suggested that lesion
size could act as a confidence score for ‘‘presence/absence studies’’
linked to normal clinical practice. However this approach is flawed
as lesion size cannot be measured when there is no lesion.
Many studies are hybrids between these two scenarios. For
example not all images may contain a lesion, and readers may be
asked to classify lesions when present and use a different
confidence score when not. Similarly ‘‘detection’’ studies may
require readers to report confidence scores for abnormalities that
they do not classify as lesions.
Aim of research
In this paper we compare two statistical methods for measuring
diagnostic performance, namely sensitivity and specificity versus
ROC AUC. When used to compare two diagnostic tests these
methods may estimate diagnostic performance differently. In this
article we investigate why this can happen using data from a
previously published clinical study [12] and examine which aspects
of study design and characteristics of the data contributed to ROC
AUC method assumptions being considered inappropriate.
We illustrate the issues using a study comparing CT colono-
graphy with and without Computer Assisted Detection (CAD) to
identify colon polyps [12]. We compare the diagnostic measure
area under the Receiver Operating Characteristic Curve (ROC
AUC) to sensitivity and specificity. This work was motivated by an
FDA strong presumption in favour of using ROC AUC to
measure diagnostic accuracy for licensing of CAD in radiological
imaging [6]. We identify and present the problems encountered
when using ROC AUC to measure diagnostic performance.
Methods
Study design
Full methods for the study are described in the original study
publication [12]. In brief, ten radiologists each read CT
colonography images from the same 107 patients, reading images
with and without CAD assistance to detect colon polyps. Each
read was separated by two months to avoid potential recall bias,
with both test and patient order randomised for each reader. The
reference standard was a consensus of two from a panel of three
experienced and independent radiologists who read each case
combination with colonoscopy reports: 60 patients had polyps and
47 were normal.
Each reader identified polyps, noting their diameter and
location. In addition they recorded whether they believed the
patient case was normal (i.e. no polyps were seen) or abnormal
(where polyps were reported). All statistical measures were
calculated per patient since a positive CT colonography will
mean subsequent colonoscopy (where the entire colon is examined
and polyps removed). Sensitivity was the percentage of patients
identified by radiologists as having a polyp, either through true
positive or false positive polyp identification(s), from patients
positive according to the reference standard. This definition of
sensitivity reflects that patients are referred based on identification
of polyps in the clinical referral pathway. Specificity is the
percentage of patients where no polyps were reported by
Exploration of Analysis Methods for Diagnostic Imaging Tests
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radiologists, of those classified as negative by the reference
standard. Table 1 shows the steps used to calculate ROC AUC
in this study. A confidence score between 1 and 100 was reported
for each potential polyp identified, with readers instructed to use
scores of 25 or above for polyps with high confidence and scores of
1 to 24 for abnormalities believed more likely to be something else.
Where no confidence score was recorded by radiologists, a zero
score was introduced during statistical analysis. Where more than
one polyp was recorded per patient, the highest confidence score
recorded with each patient was used for analysis. ROC AUC
calculations used DBM MRMC v2.1 (http://www-radiology.
uchicago.edu/krl/KRL_ROC/software_index6.htm) and Pro-
proc v0.0 (http://metz-roc.uchicago.edu/MetzROC/software/
software) [13]. DBM MRMC fits ROC curves based on
parametric binormal methods [14]. PROPROC fits ROC curves
based on a maximum-likelihood estimation using a proper
binormal distribution [13]. In this paper, for illustrative purposes,
we selected five of the ten readers that best demonstrate issues
when comparing sensitivity and specificity versus ROC AUC.
Results
Different diagnostic performance
We compared the diagnostic performance of two tests to detect
colonic polyps, CT colonography either with or without CAD,
using the difference in diagnostic accuracy measured by (i) the
number of patients correctly diagnosed and (ii) ROC AUC. We
expected diagnostic performance to increase when CAD was used.
However, we observed no clear relationship between these two
measures of diagnostic performance despite readers and cases
being identical (Figure 1A).
We then investigated the relationship between the difference in
sensitivity and specificity and the difference in ROC AUC (DROC
AUC) for individual readers, focussing on five of the ten readers as
illustrative examples (Figure 1B & 1C). Readers 2, 3 and 5
exhibited clear gains in sensitivity of 21, 22 and 21%, along with
decreases in specificity of 15, 11 and 8% respectively. Reader 5
had the best performance followed by readers 3 and 2 respectively.
Reader 4 also had a 13% increase in sensitivity with a smaller 4%
decrease in specificity. Reader 1, by contrast, showed no increase
in sensitivity but unusually had a 4% increase in specificity. Use of
CAD improved clinical diagnosis in readers 2 to 5 but not in
reader 1, based on the large increases in sensitivity when using
CAD. As noted above, these are considered more important to
both clinicians and patients than smaller reductions in specificity
[8]. By contrast, the change in ROC AUC (Figure 1B) defines a
positive benefit of CAD in readers 1 and 5 and a negative benefit
in readers 2, 3 and 4. Perversely, reader 1 had one of the highest
increases in ROC AUC (Figure 1A and 1B) since CAD had no
influence on sensitivity, the most clinically important aspect, and
also had little impact on specificity.
Problems recording confidence scores that cause zero
values
During our study readers encountered several problems when
assigning the confidence scores needed to derive ROC AUC. A
key problem was that radiologists only reported confidence scores
for regions of the colon where they identified polyps, despite
instructions to use confidence scores between 1 and 25 to report
irregularities that were, on balance, likely not polyps. CT
colonography of a normal colon identifies many potential
abnormalities that are ultimately proven not to be polyps, often
numerous, and it was impracticable to score all of these or to select
a meaningful subset to score. Further, when an abnormality
believed to be a polyp was encountered, it tended to be reported
with high confidence. In order to include all patients in the study,
the statistician or data manager assigned a value of zero when a
confidence score was not assigned by a radiologist.
Figure 2 shows the distribution of confidence scores for five
readers. The most common score for every reader was zero. This
zero-inflated ‘‘spike’’ then accompanies a second distribution of
the confidence scores assigned for abnormalities believed to be
polyps. This results in a bimodal distribution of confidence scores
that cannot be not transformed to a normal distribution by simple
data transformations used in standard open source software [15]
developed for these analyses (Figure 2). Despite instructions in
which distinct ranges of scores were linked to descriptions of
confidence, each reader interprets the guidance differently and
uses the scores in different ways.
Examples of distributions of confidence scores from
literature
Very few published articles using MRMC ROC AUC report
the distribution of confidence scores. We identified only two
examples from the literature where individual reader scores were
reported and another where the distribution of scores across the
group of readers was shown (Figure 3 [16–18]). These examples
show clearly that the distribution of confidence scores is not close
to normality in either patient group, with or without monotonic
Table 1. Steps in calculation of ROC AUC.
Step A: Assigning confidence scores
N Confidence scores were assigned by radiologists. Missing values assigned a value of zero by the data manager or statistician.
Step B: Building the ROC curve from confidence scores and calculating ROC AUC
N Distributions of the confidence scores were examined. Evaluation of potential limitations arising from non-normal distributions or extreme values.
N Real data points directly generated from confidence scores presented in ROC space
N ROC curves fitted using both parametric and nonparametric methods and examination of differences in resulting ROC AUCs. Evaluation of sensitivity of ROC curve to
key values (such as values of confidence scores if few false positives), especially important as there are few false positive results.
N ROC AUC calculated using both parametric and nonparametric methods
Step C: ROC AUC averaged across multiple readers and cases
N Different models using fixed and random effects used to model data
N Random effects with 95% confidence intervals modelled by resampling (bootstrap [40]). Alternative methods can include jackknife [41]), permutation [42] or
probabilistic method [43].
doi:10.1371/journal.pone.0107633.t001
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transformation. However they generally have one peak (unimodal)
rather than distributions with more than one peak, as observed in
our study.
Authors of two other studies where confidence scores were used
to rate the presence or absence of polyps in CT colonography,
reported that scores were non-normal [19] [20]. Baker et al. stated
this as a reason why MRMC ROC AUC analysis was not used
[19]. Petrick et al noted that the lack of normally distributed scores
led to empirical ROC analysis only via bespoke alteration to the
software used, as standard parametric binormal ROC curve fitting
could not be used [20].
Position of data points on a ROC curve
ROC curves are constructed by calculating sensitivity and
specificity at all possible thresholds of confidence score to define a
positive test result. Figure 4 shows the actual data points
underlying ROC curves in our study. Fitting a ROC curve across
all values of specificity requires extensive extrapolation beyond the
study data with the result that the area underneath the
extrapolated curve dominates ROC AUC rather than being
driven by observed data.
Fitting a ROC curve and calculating ROC AUC
Different methods can be used to fit ROC curves. These can
generate different curves from the same study data and so produce
different ROC AUCs. Figure 4 shows two curve fitting methods
available in the Metz programs; the DBM MRMC method based
on parametric binormal methods [14] (dotted line), and the
PROPROC method based on ‘proper’ binormal distributions [13]
(solid line). Non-parametric methods can also be used [21]. For
readers 2 and 5 the extrapolated portion of the ROC curves differ
greatly, demonstrating how the fitting method chosen can
influence the calculated ROC AUC. Further, for reader 4 the
DBM MRMC method was unable to fit a curve, as there were no
false positive diagnoses. Table 2 shows ROC AUCs generated
from these two methods and also using the Wilcoxon method,
which is a non-parametric method that makes no assumptions
regarding data distribution and which can be calculated without
fitting any ROC curve. It should be noted that in many published
clinical studies, the difference in ROC AUC between two tests
being compared tends to be small, in the region of 0.07 [22,23].
Impact of few false positives on ROC AUC
A further undesirable characteristic of the surrogate endpoint
DROC AUC in our study, was the large difference in DROC
AUC precipitated by small differences in the confidence scores
ascribed to false positives. Figure 5 shows the ROC curves of one
reader (reader 4 in other figures) with two false positive detections
with confidence scores of 40 and 50 respectively (reader 4
figure 2). This corresponds to the curve in orange and a ROC
AUC of 0.84. Artificially increasing these two confidence scores to
70 increases the ROC AUC to 0.96 (yellow curve), whereas
changing them to 20 and 70 respectively results in an ROC AUC
of 0.92 (brown curve). Thus the shape of the ROC curve is heavily
Figure 1. Difference in diagnostic performance of two tests showing readers from a multi-reader study. Change in diagnostic
performance of CT colonography for the detection of polyps; difference with computer assisted detection (CAD) minus without CAD. Results from
individual readers. A. Comparison of increase in the number of patients with a correct diagnosis with change in ROC AUC. The five readers selected
for illustrative purposes as examples for the rest of the article are labelled from 1 to 5. B. Arrows indicate values of sensitivity and specificity for each
reader, the arrow bases showing unassisted read values and the arrow head the CAD assisted read values for the same reader. C. Difference in ROC
AUC using two methods for fitting ROC curves. ROC AUC could not be calculated for reader 4 using LabMRMC method.
doi:10.1371/journal.pone.0107633.g001
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dependent on the relative ranking of confidence scores ascribed to
two false positive patients versus true positive diagnoses. In our
study the median number of patients with false positive scores per
reader in unassisted reads was 2 of 107 patients, demonstrating
how ROC AUC may be influenced heavily by a very small
proportion of the observed data.
Discussion
Standard measures and ROC AUC do not correlate
We compared two diagnostic measures: ROC AUC, the
percentage of patients with a correct diagnosis, and sensitivity
and specificity, to quantify the impact of using CT colonography
with and without CAD. Each measure was calculated for
interpretation of the same patients by the same reader.
Diagnostic performance between imaging tests is often assessed
by the difference in ROC AUC, which is the measure preferred by
the FDA for regulatory licensing [6]. We favour using the
difference in sensitivity and difference in specificity, as these can
calculated using test measurements made in clinical practice,
which are direct measures measured from real patients (i.e.
without need for confidence scores). By contrast ROC AUC is a
surrogate measure, as it does not assess test performance at a
relevant clinical threshold, but instead assesses performance
averaged over all possible thresholds.
In our study, the change in ROC AUC was not correlated with
the change in the proportion of patients correctly diagnosed, for
the same readers interpreting the same patients (Figure 1).
Readers in whom a decrease in ROC AUC indicated decreased
accuracy when using CAD actually exhibited increased accuracy
when assessed by the difference in sensitivity and specificity
(Figure 1B and 1C).
Problems with confidence scores of zero
ROC AUC analysis requires confidence scores of diagnostic
certainty to build the ROC curve. In our study we found that
radiologists did not assign confidence scores in patients in whom
they detected no abnormality. A zero score was therefore assigned
by the study statistician in order to include all patients in the
analysis (Figure 2). These scores then had an adverse effect on the
analysis in several ways:
Firstly, some scores are default values of zero when no score was
defined by radiologists in this study. Less obviously, the zero scores
are a score based on whole patient diagnosis at an almost infinite
number of locations in CT colonography where an abnormality
might have been detected, whereas when an abnormality is
detected the score is based on that specific region of interest within
the image. Also, radiologists interpret and assign scores differently,
despite receiving the same scoring instructions.
Secondly, there are often two types of true negative scores. In
our study true negatives could result either because the colon wall
was perceived to be normal or when an abnormality was perceived
but was correctly identified (and scored) as not being a polyp. In a
mammographic comparison of digital and film techniques, two
types of true negative findings are also described; the first where no
finding was identified and the second where a finding was
identified but was thought to be benign rather than malignant
[11]. Study designs where every image includes a lesion may have
only one type of true negative (e.g. a lesion is seen but is believed to
be benign rather than malignant), but most other studies are likely
Figure 2. Distribution of confidence scores for patients with and without polyps. Each histogram shows the distribution of confidence
score values using CAD CT colonography for an individual reader separately for patients with (brown) and without polyps (yellow) based on the
reference standard. Five readers are shown in plots labelled 1 to 5.
doi:10.1371/journal.pone.0107633.g002
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Figure 3. Distribution of published confidence scores. Published confidence scores assigned by individual readers (Reader 1 and Reader 2)
reported for patients without disease (DN) and patients with disease (DP) from two studies. In Hussain et al. [17], classification of MR imaging of
Exploration of Analysis Methods for Diagnostic Imaging Tests
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to have more than one type of true negative if they include patients
with no abnormality.
A third issue is that in studies comparing two tests, there is an
expectation that a better test will increase confidence scores.
However for true negative results due to ‘‘normal’’ patients there is
no room for improvement since a score of zero cannot be
decreased further. Where there are a large number of such true
negatives, there is little ability to demonstrate any diagnostic
improvement.
A fourth and important issue is that zero scores mean that the
basic requirement for a ROC curve to summarise all data in a
valid fashion is broken, namely that the data is normally
distributed or can be transformed to a normal distribution by a
monotonic function [24]. In our study, the data from all patients
where a zero score was assigned only contribute to the point at the
origin of the ROC curve at the top right hand corner of the plot
and so do not contribute to the shape of the curve. The ROC
AUC then becomes a summary of a subset of the study data and,
as in our study, is likely not to include data from a large proportion
of patients in whom no abnormality was detected. These patients
include both those with a true negative result and those with a false
negative result. In our study, due to high specificity indicating
good test performance, 80% to 100% of TN patients were not
included in the ROC curve. In addition due to a lower sensitivity
between 28% to 77%, FN patients were also excluded. Overall,
only 15% to 47% of the 107 patients in the study actually
contributed to the ROC curve and, therefore, the ROC AUC.
Harrington pertinently highlights this as a key issue, noting that
ROC AUC is silent on false-negative and true-negative diagnoses
despite their substantial clinical importance [25]. The distribution
of confidence scores in our study was bimodal and resembles the
distribution of rainfall data, where there are definite zero values
(days on which there is no rain) together with continuous scores
(reflecting the amount of rain on those days when it does rain).
Problems modelling rainfall data are well-recognised, due to the
lack of continuity between the zero scores (binary data) and those
that are continuous. Thus rainfall models are often split; one
model describes the probability that a day is wet or dry (binary
data), and a second describes the amount of rain when the weather
is wet (continuous data) [26].
There are significant issues with modelling data that is neither
solely discrete nor continuous. Accordingly, we feel it is
inappropriate to model such data in the simple binormal format
to calculate a ROC curve.
Other problems with confidence score distribution
The distribution of confidence scores can also cause problems
even where there are no problems with zero scores. ROC AUC
was introduced to medical diagnosis [27] based on its ability to
cirrohotic liver used categories: 1 definitely benign; 2 probably benign; 3 possibly malignant; 4 definitely malignant. In Westphalen et al. [18],
classification of MR imaging of peripheral zone tissue from patients with prostate cancer used categories: 1 likely benign; 2 possibly benign; 3
equivocal or indeterminate; 4 possibly malignant; 5 likely malignant.
doi:10.1371/journal.pone.0107633.g003
Figure 4. Different curve fitting methods. ROC plots each for an individual reader using CT colonography without CAD. Green dots indicate real
data points underlying curve fitting. ROC curve are shown extrapolated from these data using DBM MRMC (red dotted line) and PROPROC software
(blue solid line). Five readers are shown in plots labelled 1 to 5.
doi:10.1371/journal.pone.0107633.g004
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distinguish between two diagnostic alternatives (with and without
target condition or disease) and assuming the distributions of
confidence scores are normally distributed for patients both with
and without disease. However most radiological tests are clinically
useful because they facilitate identification of patients with disease
or ruling out patients who don’t have disease, and so the
distributions of confidence scores for either or both sets of patients
are usually not normally distributed. Disappointingly, most papers
that cite the MRMC using DBMMRMC or Metz software do not
report the distribution of confidence scores in their data. Figure 3
shows two examples of distributions of confidence scores from our
study, which demonstrate the characteristic of extreme scores in
patients either with or without disease. Hanley has shown that for
classification studies with a small number of rating categories,
ROC curves can be reasonable under a mixture of normal
distributions even for data with highly non normal distributions
[28]. However others have raised concerns for ROC AUC analysis
for tests intended to identify well defined abnormalities [29] (i.e.
tests where there are few false positive results such as diagnosis of
ankle fractures using single view radiographs [30]). With well
defined abnormalities, there are two issues: firstly the distribution
of confidence scores is highly non-normal and cannot be
transformed to a normal distribution, and secondly there may be
few false positive results that then lead to curve fitting problems
(see figure 5). Both of these components lead to a situation where
confidence scores for patients with and without disease do not
have sufficient overlap to fit a reliable ROC model. Where there is
little overlap, then confidence scores essentially represent binary
decisions, possibly with an equivocal category. Reviewing several
of his studies for detection of well defined abnormalities, Gur
found that with a few exceptions, more than 90% of interpreta-
tions had scores at the extremes of the range (i.e. greater than 89%
or less than 11% on the confidence scale) [29]. Gur suggested this
might be a particular characteristic of detection studies, as opposed
to characterisation studies. Dorfman et al have also identified
issues when using ROC AUC to analyse tests that dichotomise
into clearly positive and negative results, and so generate few false
positives [30].
One suggestion is that when confidence scores are not normally
distributed, readers are re-trained to spread their confidence scores
across the full range of the available scale [31]. We share the
concerns expressed by Gur that this process intended to achieve a
better spread of data specifically for ROC analysis raises doubts
about subsequent generalisability of findings to the clinical
environment [29]. We also note that the ranking methods used
to analyse confidence scores in DBM MRMC software acts to
condense and reduce the difference between scores in cases where
there is good separation of scores due to well-defined abnormal-
ities. These ranking methods will therefore undervalue the
discrimination of better tests [32] whereas tests with poorer
discrimination between confidence scores will be overvalued.
Unfortunately, the better the test, the worse ROC methodology
performs as an analysis tool due to confidence scores being
concentrated at extreme values or violating distributional
assumptions. Perversely, the worse the imaging test, the better
these statistical methods make it appear.
Although studies using typical characterisation categories such
as ‘normal’, ‘probably normal’, ‘equivocal’, ‘probably abnormal’,
or ‘definitely abnormal’ may avoid problems with normality
assumptions [28], other key issues arise since these categories do
not conform to an evenly spaced ordinal score giving an ROC
AUC value which is harder to interpret [25]. Some scoring
systems such as BI-RADS (Breast Imaging-Reporting and Data
System) have been analysed using ROC AUC but are not ordinal.
Table 2. ROC AUC using different methods and different ROC curves.
Reader Wilcoxon ROC AUC (SE) DBM MRMC ROC AUC (SE) PROPROC ROC AUC (SE)
1 0.724 (0.048) 0.814 (0.123) 0.814 (0.120)
2 0.737 (0.048) 0.922 (0.073) 0.952 (0.034)
3 0.732 (0.048) 0.887 (0.105) 0.887 (0.105)
4 NC (NC) NC (NC) 1 (NC)
5 0.589 (0.055) 0.469 (0.141) 0.641 (0.046)
ROC AUC and standard errors calculated for five readers using CT colonography without CAD.
The Wilcoxon method is equivalent to the Wilcoxon statistic, an empirical method not requiring a ROC curve to be fitted. DBM and PROPROC methods sometimes give
different ROC AUC because different ROC curves are fitted as seen in figure 5 for Readers 2 and 5. NC = could not be calculated with DBM MRMC software.
doi:10.1371/journal.pone.0107633.t002
Figure 5. Impact of few false positives. ROC curve for reader 4
using CT colonography with CAD. The data from the original read
(orange curve) includes two patients where false positive polyps have
been indicated with confidence scores of 40 and 50. Perturbing these
two patient scores to values of 70 (yellow curve) and 20 and 70 (brown
curve) demonstrate changes in ROC curves. Sensitivity and specificity
are expressed as percentages.
doi:10.1371/journal.pone.0107633.g005
Exploration of Analysis Methods for Diagnostic Imaging Tests
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A BI-RADS rating of 2, defined as benign abnormality, does not
imply a greater suspicion of cancer than a BI-RADS rating of 1,
which is defined as no abnormality; both are confident diagnoses
of non-malignancy. Concerns about using such non ordinal scores
in ROC AUC analyses have been raised [25].
Furthermore, confidence scores for classification of abnormality
in radiological studies are not based on a single characteristic, but
are a composite assessment often including assessments of size,
shape, morphology and other visual information [25]. The
component parts of this composite score are not constrained to
ensure they are used equivalently by different readers in a multi-
reader study. Indeed a lack of constraint is also likely to mean that
scores are used differently even within a single reader comparing
two tests in the same patient. Harrington further points out that
there is no evidence that confidence levels are reported in a
consistent, reliable basis throughout a single experiment by all
radiologists or even within each radiologist, an assumption
important in ROC construction and interpretation of ROC
AUC He outlines how the basis of confidence ratings vary across
radiologists and lists 10 different interpretations when radiologists
were asked to define ‘‘high confidence’’, varying from ‘‘the image
quality is good’’, ‘‘the finding is obvious’’, ‘‘the finding is familiar’’,
to confidence in their own judgement [25]. The lack of a defined
objective measure of confidence means there is no standard to
ensure consistency of confidence scores within or between readers
across interpretations and when comparing tests. This explains
why we found very different values and distributions of confidence
scores in our study (Figure 2).
Issues when confidence scores are disconnected from
normal clinical practice
Confidence scores for ROC AUC analysis can be obtained
either by adapting standard clinical reporting scales (e.g. BI-
RADS) or by using scales specifically designed to calculate ROC
AUC. The advantage of using non-standard scores is that these
can be specifically designed to improve statistical power and fit
with statistical assumptions. Such scales are often wide (e.g. from 1
to 100) and are clearly ordinal. However there can be problems
with how such scores are used by radiologists and extrapolation to
a clinical context.
When confidence scores are not based on standard clinical
categories, the ROC curve does not correspond to a clinical
decision curve but is based on what Dorfman et al have termed
virtual operating points [30]. The interpretation and relevance of
derived performance measures such as ROC AUC is then
problematic unless the ROC curve is identical when confidence
scores based on standard clinical categories are used [25]. Given
the problems of interpreting ROC AUC when based on
confidence scores disconnected from clinical categories, sugges-
tions as to how to train readers to distribute their scores to reduce
violation of statistical assumptions seem somewhat to have lost
clinical relevance [31]. When confidence scores are disconnected
from normal clinical practice there are problems in how
radiologists assign such scores, particularly when the concepts
underlying them may be counter to concepts used in standard
clinical systems. Krupinski [33] comments on the disconnect
between the confidence scores used in the ‘‘laboratory’’ to assess
CAD assisted mammography versus the BI-RADS scales and
binary endpoints used by radiologists in clinical practice. Gur [29]
is similarly concerned that where there are well defined
abnormalities, an attempt to use continuous confidence scores
imposes a mismatch between the study and the readers’ normal
clinical situation. When forced to score confidence for a well
defined abnormality, readers may resort to scoring on their
assessment of lesion subtlety or lesion size rather than their
confidence of seeing the abnormality. In support of that idea, we
found an association between confidence scores and polyp size.
ROC curves
In a study like ours, the shape of the ROC curve, and hence the
value of ROC AUC is likely to be highly dependent on the scores
for a few false positive results (Table 2 & Figure 5). Gur et al found
curve fitting was highly dependent on the last experimentally
ascertained data point [34] particularly where there are well
defined abnormalities [29]. The last experimentally ascertained
data points are those with the lowest specificity values and are
highly influenced by confidence scores assigned to false positive
diagnoses.
Different curve fitting methods can produce different curves for
the same data (Figure 4), with very different resulting values for
the ROC AUC (Table 2). This phenomenon can be particularly
pronounced when data points are restricted to a very small part of
the graph so that extensive extrapolation is required to draw the
curve and calculate ROC AUC. Other researchers have also
found that different methods can calculate different ROC AUC
values [35] and this is recognised in FDA guidelines where it is
specified that both parametric and non parametric methods
should be used [6].
Some curve fitting methods failed with our data because some
readers did not identify any false positive results (also known as
‘‘degenerate’’ data). A similar study to ours, using CT colono-
graphy to detect polyps, also experienced difficulties with fitting
curves using the parametric methods included in DBM MRMC
software, and reported that empirical ROC analysis was used
instead [20]. However this may merely move the issues elsewhere;
Gur et al found empirical non-parametric methods of fitting ROC
curves highly dependent on the last experimentally ascertained
data point, to a greater degree than ROC curves fitted using
parametric methods [34]. Furthermore with data similar to our
study, the ROC curve itself does not represent a good summary of
all patient data due to the large proportion of patients with
extreme confidence score values.
One way to reduce the influence of extrapolation from the study
data and therefore weight the ROC AUC to the most clinically
relevant data, is to use a partial ROC AUC, for example restricted
to values between 75% to 100% specificity (i.e. 1-specificity in the
range of 0% to 25%). However using a partial ROC AUC
introduces new problems including the arbitrary choice of
thresholds, which can affect which readers would have the highest
ROC AUC [1]. The choice of threshold is particularly challenging
to justify in a study such as ours with ten different readers and two
tests, all with data points extending across slightly different ranges
of specificity [34].
Interpreting ROC AUC
Three common interpretations of ROC AUC have been
proposed [36]; the average test sensitivity across all possible values
of specificity; the average specificity across all possible values of
sensitivity; the probability that randomly selected pairs of patients,
one with and one without disease, would be ordered correctly for
probability of disease.
Figure 4 illustrates why in our study we are not interested in the
average value of sensitivity across all possible values of specificity,
as most values of specificity do not occur in clinical practice with
our test. The dots show real data corresponding to the range of
thresholds at which our tests perform in clinical practice. Similarly
not all values of sensitivity are used in practice. The probability
that randomly selected pairs of patients, one with and one without
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disease, would be ordered correctly for probability of disease is not
useful in clinical practice as patients do not attend outpatient
clinics in pairs! [37]
ROC AUC is widely presented as a measure that avoids
mistakes arising from comparing tests at single thresholds,
particularly if ROC curves cross [38]. However some authors
caution that when ROC curves cross or have different shapes,
comparisons of ROC AUC are invalid [39]. We presented further
problems with ROC AUC and its interpretation for patients in a
previous article [1].
Some proponents of ROC AUC view the shift in sensitivity and
specificity seen in our study as not indicating a change in
diagnostic performance, because ROC curves with and without
CAD overlap, and dismiss the increased sensitivity as simply
corresponding to a change in test threshold. Using a microscope to
identify cytological abnormalities magnifies cells and hence
changes the test threshold at which abnormalities can be detected,
but this threshold change is not seen as irrelevant to clinical
practice. In the same way, we maintain that to change the average
operating threshold of a test across readers using CAD CT
colonography should not be disregarded as an irrelevance, but
assessed according to its impact on the accurate diagnosis of
patients.
Conclusions
In our study comparisons of diagnostic performance derived
from differences in ROC AUC led to very different conclusions
than differences in sensitivity and specificity. Assigning confidence
scores was found to be problematic in this detection study and the
distribution of these scores was highly non-normal with the result
that the ROC curve only summarised data from between 15% to
47% of the 107 patients per reader. Differences in curve fitting and
methods for calculating ROC AUC led to differences in calculated
values which were greater than the typical difference in ROC
AUC observed in published studies. We summarise problems
reported by other researchers and caution trialists to examine their
study design and data to establish whether ROC AUC assump-
tions are likely to be met, particularly for detection studies. In our
study sensitivity and specificity give a more clinically relevant
summary of diagnostic performance since they are based on the
diagnostic decisions used to guide clinical management.
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